ImmuCell Corporation Accounts Payable, Other, Current
ImmuCell Corporation (ICCC) had Accounts Payable, Other, Current of $420.14 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current › Accounts Payable, Current
us-gaap:AccountsPayableOtherCurrent · last filed 2025-08-14
- 2025-06-30: Accounts Payable, Other, Current $420.14K.
- 2025-03-31: Accounts Payable, Other, Current $26.00K.
- 2024-12-31: Accounts Payable, Other, Current $8.75K.
- 2024-09-30: Accounts Payable, Other, Current $6.38K.
| Period end | Accounts Payable, Other, Current |
|---|---|
| 2025-06-30 | $420.14K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $26.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.75K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $6.38K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.17K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $11.72K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $13.18K 10-K · filed 2025-03-28 |
| 2023-09-30 | $6.82K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $122.10K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $60.64K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $63.26K 10-K · filed 2024-04-01 |
| 2022-09-30 | $78.58K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $33.46K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $66.16K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $18.26K 10-K · filed 2023-03-29 |
| 2021-09-30 | $48.53K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $74.44K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $80.21K 10-Q · filed 2021-05-13 |
| 2020-09-30 | $19.93K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $150.36K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $384.63K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $170.22K 10-K · filed 2021-03-30 |
| 2019-09-30 | $17.50K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.21K 10-Q · filed 2019-08-12 |
| 2018-12-31 | $72.69K 10-K · filed 2020-03-27 |
| 2018-09-30 | $51.43K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $7.04K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $67.10K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $641.39K 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.54M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $2.96M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $850.32K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $1.25M 10-K · filed 2018-03-29 |
| 2016-09-30 | $165.15K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $329.73K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $102.19K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $1.51K 10-K · filed 2017-03-30 |
| 2015-09-30 | $37.97K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $60.61K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $99.80K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $251.38K 10-K · filed 2016-03-25 |
| 2013-12-31 | $23.50K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |